# Comparison of the Combination of Fenofibrate and Simvastatin Versus Pravastatin

> **NCT00362206** · PHASE3 · COMPLETED · sponsor: **Solvay Pharmaceuticals** · enrollment: 423 (actual)

## Conditions studied

- Hyperlipidemia

## Interventions

- **DRUG:** Fenofibrate/Simvastatin
- **DRUG:** Fenofibrate/Simvastatin
- **DRUG:** Pravastatin

## Key facts

- **NCT ID:** NCT00362206
- **Lead sponsor:** Solvay Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-09
- **Primary completion:** 2008-09
- **Final completion:** 2008-09
- **Target enrollment:** 423 (ACTUAL)
- **Last updated:** 2009-07-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00362206

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00362206, "Comparison of the Combination of Fenofibrate and Simvastatin Versus Pravastatin". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00362206. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*